Supplementary Figure 1 Logan et al
IP Ab
HSF
1Irr w
e
p63
Supplementary Figure 2 Logan et al
F/l
1-42
1-292
248-393
Pro
I II III IVV
TAD DBD Oligo
HSF1 Int.
+
-
++
-
F/l Pro1-2
9224
8-39
3
1-42
GST
Pull down
Inputs
PG13 MG15 p21-luc0123456789
10
+ p53 - p53
Rel
ativ
e ch
ang
e
Supplementary Figure 4 Logan et al
Supplementary Figure 3 Logan et al
0
2
4
6
8
10
12etopactDdox
untp21 WAF1
Rel
ativ
e q
uan
tity
Rel
ativ
e re
cru
itm
ent
unt dox etop
5545
actD012345
2535
gadd45
p53 HSF1
irr
Supplementary Figure 5 Logan et al
Supplementary Figure 6 Logan et algadd45
ns p53
HS
F1
HSF1 ChIPp53 ChIP
0
20
40
60
80
100
Rel
ativ
e re
cru
itm
ent
siRNA
Supplementary Figure 7 Logan et al
p53 ser15 DAPI
HSF1 +/+
Unt
dox
Unt
dox
HSF1 -/-